Home > Insider Trading > Filing (0001179110-21-004535)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1808968	B. Matthew Klein	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-04-19	859	$48.17	18,450	No	4	S	Direct
Common Stock	Disposition	2021-04-20	1,444	$46.58	17,006	No	4	S	Direct
Common Stock	Disposition	2021-04-20	197	$47.92	16,809	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from a April 16, 2020 grant of 10,000 RSUs.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 10, 2021.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.24 to $47.06 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.68 to $48.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.